0001161697-24-000024.txt : 20240103
0001161697-24-000024.hdr.sgml : 20240103
20240103171853
ACCESSION NUMBER: 0001161697-24-000024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daly Richard J
CENTRAL INDEX KEY: 0001635393
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 24508175
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 1500
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 01-01-2024
X0508
4
2024-01-01
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001635393
Daly Richard J
355 ALHAMBRA CIRCLE
SUITE 801
CORAL GABLES
FL
33134
1
1
0
0
President and CEO
0
Options to purchase common stock
13.30
2024-01-01
4
A
0
1365319
0
A
2031-01-01
Common Stock
1365319
1564486
D
Restricted Stock Units
2024-01-01
4
A
0
210526
0
A
Common Stock
210526
1775012
D
Price of derivative security is based upon the date on which the Reporting Person's executed their offer letter (dated October 18, 2023) with the Registrant, in accordance with the Registrant's 2018 Stock Incentive Plan. Mr. Daly became the Registrant's President and Chief Executive Officer on January 1, 2024 and remains a member of the Registrant's Board of Directors.
Derivative securities vest in five equal annual tranches beginning on January 1, 2025.
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
Shares of common stock will be delivered to the Reporting Person upon vesting.
/s/ Richard J. Daly
2024-01-03